Cardiotrack, a Bengaluru, India-based provider of data-centric healthcare screening technology and services, raised US$2M in Pre-Series A funding.
The round was led by Girish Narasimhan.
The company, which had previously received angel investment of US$1.6M from a cohort of UHNIs, intends to use the funds to expand operations and its R&D sector.
Led by Founder and CEO Avin Agarwal, Cardiotrack delivers at-home pathology and radiology screening services, in 300+ locations through its pan-India network of diagnostic centers, technicians and phlebotomists equipped with its technology, for its customers. The company offers medical and IOT grade diagnostics devices, workflow automation and health data digitisation solutions that empower health & life insurance providers to offer seamless onboarding experiences while enabling their customers to take control of their health.
Currently, it serves nine health and life insurance companies, including most of the largest insurers in India.
Commenting on the news, Avin Agarwal said: “We are thrilled to have secured this investment as we continue to innovate and expand our reach in our mission to drive positive change in the healthcare industry. Our revolutionary approach to healthcare screening not only enhances convenience for consumers but also enables health and life insurance providers to offer fast, comprehensive and personalised services, besides increased operational efficiency and improving our healthcare data analytics capabilities for faster and more accurate insurance underwriting. The investment further validates the venture’s direction and the immense value it brings in improving the healthcare experience for both providers and consumers.”
FinSMEs
04/03/2024